Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin (Q24605776)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin |
scientific article |
Statements
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin (English)
0 references
Corey J Langer
Corey J
Langer
Daniel D Karp
Michael N Pollak
Roger B Cohen
Peter D Eisenberg
Paul Haluska
Donghua Yin
Allan Lipton
Laurence Demers
Kim Leitzel
Mary L Hixon
Leon W Terstappen
Linda Garland
Luis G Paz-Ares
Felipe Cardenal
Antonio Gualberto
November 2009
0 references
4
0 references
11
0 references
1397-403
0 references